Ampio Pharmaceuticals Inc. short interest in 2023
In 2023, Ampio Pharmaceuticals Inc.'s disclosed short interest ran from 1.30% of shares outstanding on 13 Jan 2023 to 8.64% on 29 Dec 2023, a change of +7.34 percentage points. The year's high was 9.44% on 15 Dec 2023 and its low 1.09% on 31 Jan 2023, averaging 2.68% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.74 days on 31 Jul 2023. Full history: Ampio Pharmaceuticals Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024
2023 in figures
- Start of year
- 1.30% (13 Jan 2023)
- End of year
- 8.64% (29 Dec 2023)
- Change
- +7.34 pp
- High
- 9.44% (15 Dec 2023)
- Low
- 1.09% (31 Jan 2023)
- Average
- 2.68%
- Highest days to cover
- 4.74 (31 Jul 2023)
- SEC filings marked
- 4
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 1.30% | 1.00 | |
| 31 Jan 2023 | 1.09% | 1.10 | |
| 15 Feb 2023 | 1.10% | 1.82 | |
| 28 Feb 2023 | 1.14% | 1.01 | |
| 15 Mar 2023 | 1.23% | 2.42 | |
| 31 Mar 2023 | 1.47% | 1.54 | 10-K filed |
| 14 Apr 2023 | 1.17% | 1.48 | |
| 28 Apr 2023 | 1.46% | 1.00 | |
| 31 May 2023 | 2.96% | 1.27 | 10-Q filed |
| 15 Jun 2023 | 2.20% | 1.85 | |
| 30 Jun 2023 | 2.10% | 4.65 | |
| 14 Jul 2023 | 2.11% | 4.46 | |
| 31 Jul 2023 | 1.82% | 4.74 | |
| 15 Aug 2023 | 2.76% | 1.00 | 10-Q filed |
| 31 Aug 2023 | 2.82% | 1.78 | |
| 15 Nov 2023 | 1.86% | 1.00 | 10-Q filed |
| 30 Nov 2023 | 4.22% | 1.00 | |
| 15 Dec 2023 | 9.44% | 1.00 | |
| 29 Dec 2023 | 8.64% | 1.00 |
See also: Ampio Pharmaceuticals Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.